设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

副总编辑:魏永祥、张运、

罗毅、谭学瑞、唐来坤、

王喜艳

编辑部主任:杨秋

邮发代号:80-528
定价:20.00元
全年:240.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2020 年第 2 期 第 15 卷

低分子肝素联合阿司匹林在儿童心导管术后股动脉血栓治疗中的效果

Effect of low molecular weight heparin combined with aspirin on femoral artery thrombosis after cardiac catheterization in children

作者:戴辰程何楠肖燕燕王霄芳郭保静焦萌梁永梅李刚金梅

英文作者:

单位:首都医科大学附属北京安贞医院小儿心脏中心100029 

英文单位:

关键词:心导管术;股动脉血栓;低分子肝素;阿司匹林

英文关键词:

  • 摘要:
  • 【摘要】目的    评价低分子肝素联合阿司匹林在儿童心导管术后股动脉血栓形成治疗中的效果。方法    回顾性分析2015年9月至2019年3月于首都医科大学附属北京安贞医院小儿心脏中心行心导管术后24 h仍存在股动脉血栓的10例住院患儿的临床资料、治疗经过及转归。所有患儿均给予皮下注射低分子肝素联合口服阿司匹林治疗股动脉血栓。结果    10例患儿中男2例、女8例;月龄9~80个月,平均(32±24)个月;体质量5.8~17.5 kg,平均(12±4)kg。10例患儿中7例为动脉导管未闭,1例为法洛四联症,1例为房间隔缺损,1例为阵发性室上性心动过速,股动脉血栓发生率为0.84%(10/1 189)。7例为股总动脉闭塞,1例为股浅动脉闭塞,1例为股总动脉合并股浅动脉血栓闭塞,1例为股总动脉中度狭窄,血栓长度0.7~2.7 cm。7例患儿于股动脉血栓形成第2天应用皮下注射低分子肝素联合口服阿司匹林治疗,1例于第3天应用,2例于第5天才应用。皮下注射低分子肝素疗程3~28 d,平均(10±8)d。口服阿司匹林最终治疗剂量2.0~4.6 mg/kg,平均(3.2±0.8)mg/kg。所有患儿经治疗后股动脉血流均恢复正常,足背动脉搏动恢复,皮肤温度恢复正常。随访1~33个月,所有患儿超声多普勒提示股动脉血流通畅,血栓均未复发。治疗期间无出血、过敏、皮疹、消化道症状、血小板减少及肝肾功能损伤等并发症发生。结论    皮下注射低分子肝素联合口服阿司匹林治疗儿童心导管术后股动脉血栓安全有效。

  • 【Abstract】Objective    To observe the efficacy of low molecular weight heparin combined with aspirin in treatment of femoral artery thrombosis after cardiac catheterization in children. Methods    Ten children who had femoral artery thrombosis 24 h after cardiac catheterization in Beijing Anzhen Hospital, Capital Medical University from September 2015 to March 2019 were retrospectively analyzed. All children were treated with subcutaneous injection of low molecular weight heparin combined with oral aspirin. Clinical data, treatments and outcomes were analyzed. Results    There were 2 boys and 8 girls, aged 9-80 months, with an average of (32±24)months; body mass was 5.8-17.5 kg, with an average of (12±4)kg. There were 7 cases of patent ductus arteriosus, 1 case of tetralogy of Fallot, 1 case of atrial septal defect and 1 case of paroxysmal supraventricular tachycardia. The incidence of femoral artery thrombosis was 0.84%(10/1 189), including 7 cases of common femoral artery occlusion, 1 case of superficial femoral artery occlusion, 1 case of common femoral artery with superficial femoral artery thrombosis occlusion, 1 case of moderate stenosis of common femoral artery; the length of thrombus was 0.7-2.7 cm. Seven children were treated with subcutaneous injection of low molecular weight heparin combined with oral aspirin on the second day of thrombosis; 1 child started treatment on the third day and 2 children started on the fifth day. The course of low molecular weight heparin injection was 3-28 days, with an average of (10±8)d. The final dose of aspirin was 2.0-4.6 mg/kg, with an average of (3.2±0.8)mg/kg. After treatment, blood flow of femoral artery, pulsation of dorsal pedal artery and skin temperature returned to normal in all children. No thrombosis reoccurred during 1-33 months follow-up. No complications such as bleeding, allergy, rash, digestive symptoms, thrombocytopenia, liver and kidney injury were observed during treatment. Conclusion    Subcutaneous injection of low molecular weight heparin combined with oral aspirin is safe and effective in treating femoral artery thrombosis after cardiac catheterization in children.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备18043517号-1
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭